Biomarkers for atopic dermatitis: A systematic review and meta-analysis

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 5, 2015, Pages 453-460

  Thijs, Judith ^a   Krastev, Todor ^a   Weidinger, Stephan ^b   Buckens, Constantinus F ^a   De Bruin Weller, Marjolein ^a   Bruijnzeel Koomen, Carla ^a   Flohr, Carsten ^c   Hijnen, Dirkjan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

atopic dermatitis; biomarkers; cutaneous T cell attracting chemokine; disease severity measures; interleukin 18; lactate dehydrogenase; macrophage derived chemokine; sE selectin; thymus and activation regulated chemokine

Indexed keywords

BIOLOGICAL MARKER; CD30 ANTIGEN; CUTANEOUS T CELL ATTRACTING CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 31; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MACROPHAGE DERIVED CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; VITAMIN D; INTERLEUKIN 18;

ATOPIC DERMATITIS; DISEASE SEVERITY; FOLLOW UP; HUMAN; KERATINOCYTE; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW; T LYMPHOCYTE; BLOOD; DERMATITIS, ATOPIC;

BIOMARKERS; CHEMOKINE CCL17; CHEMOKINE CCL22; CHEMOKINE CCL27; DERMATITIS, ATOPIC; E-SELECTIN; HUMANS; INTERLEUKIN-18; L-LACTATE DEHYDROGENASE;

EID: 84943228904     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000198     Document Type: Review

References (22)

1. Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol 2008; 25:1-6.
2. Flohr C. Atopic dermatitis diagnostic criteria and outcome measures for clinical trials: still a mess. J Invest Dermatol 2011; 131:557-559.
3. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task Br J Dermatol 1999; 140:109-111.
4. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring J Invest Dermatol 2003; 120:932-941.
5. Schmitt J, Langan S, Stamm T, Williams HC. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol 2011; 131:623-630.
6. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62:1006-1012.
7. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-47.
8. Williams HC, Burney PGJ, Hay RJ, et al. The UK Working Party diagnosticcriteria for atopic-dermatitis 0.1. Derivation of a minimum set of discriminators for atopic-dermatitis. Br J Dermatol 1994; 131:383-396.
9. Stewart A. Basic statistics and epidemiology: a practical guide. McPherson K, editor. Radcliffe Publishing Ltd, UK; 2010. 64-66.
10. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Software 2010; 36:1-48.
11. Jackson D, Turner R, Rhodes K, Viechtbauer W. Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models. BMC Med Res Methodol 2014; 14:103.
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539-1558.
13. Sterne JA, Egger M, Smith GD. Systematic reviews in healthcare: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323:101-105.
14. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11:81-88.
15. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8:157-165.
16. Rossiter H, van Reijsen F, Mudde GC, et al. Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol 1994; 24:205-210.
17. Juhlin L, Venge P. Eosinophilic cationic protein (ECP) in skin disorders. Acta Derm Venereol 1991; 71:495-501.
18. Vestergaard C, Yoneyama H, Murai M, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999; 104:1097-1105.
19. Hata H, Yoshimoto T, Hayashi N, et al. IL-18 together with anti-CD3 antibody induces human Th1 cells to produce Th1-and Th2-cytokines and IL-8. Int Immunol 2004; 16:1733-1739.
20. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999; 162:5070-5077.
21. Hoshino T, Yagita H, Ortaldo JR, et al. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4\+ T cells. Eur J Immunol 2000; 30:1998-2006.
22. Kou K, Aihara M, Matsunaga T, et al. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis. Arch Dermatol Res 2012; 304:305-312.